Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

Authors:

Abstract
No abstract available
Funding Information
  • Sanofi
  • Fresenius Medical Care North America
  • U.S. Department of Veterans Affairs
  • Medtronic
  • Bayer HealthCare
  • Bristol-Myers Squibb
  • Duke University
  • Daiichi-Sankyo
  • Eli Lilly and Company
  • Icahn School of Medicine at Mount Sinai
  • Astellas Pharma Canada
  • Roche
  • Amarin Corporation
  • Bayer
  • Janssen Pharmaceutica
  • Daiichi Sankyo Europe
  • GlaxoSmithKline
  • Merck Sharp and Dohme United Kingdom
  • Merck
  • Portola Pharmaceuticals
  • Novartis
  • Biotronik
  • Cleveland Clinic
  • LEO Pharma Research Foundation
  • AstraZeneca
  • Boehringer Ingelheim
  • Servier
  • Pfizer

This publication has 22 references indexed in Scilit: